新冠肺炎疫情恢复期出行建议及对输入性疟疾的影响：强化疟疾的预防、早诊早治和合理用药
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria.
机构信息
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
出版信息
Clin Infect Dis. 2023 Apr 3;76(7):1161-1163. doi: 10.1093/cid/ciad061.
Return to international travel in the COVID-19 pandemic recovery period is expected to increase the number of patients with imported malaria in the United States (US). Malaria prevention in travelers and preparedness for timely diagnosis and appropriate treatment are key to minimize imported malaria morbidity and mortality. Intravenous artesunate (IVAS) is now available from commercial distributors in the US for the treatment of severe malaria. Hospitals and pharmacists should have a plan for malaria treatment, including stocking artemether-lumefantrine for uncomplicated malaria, and stocking or planning for rapid procurement of IVAS for the treatment of severe malaria.
预计在 COVID-19 大流行恢复期恢复国际旅行将增加美国（美国）输入性疟疾患者的数量。旅行者的疟疾预防以及及时诊断和适当治疗的准备工作是将输入性疟疾发病率和死亡率降至最低的关键。静脉注射青蒿琥酯（IVAS）现已可从美国的商业经销商处获得，用于治疗重症疟疾。医院和药剂师应制定疟疾治疗计划，包括储备青蒿琥酯-本芴醇治疗普通疟疾，并储备或计划快速采购 IVAS 治疗重症疟疾。
Zotero 插件